Soleno Therapeutics, Inc. (SLNO)

NASDAQ: SLNO · Real-Time Price · USD

31.72

-1.50 (-4.52%)

At close: Mar 23, 2026, 4:00 PM EDT

31.70

-0.02 (-0.06%)

After-hours: Mar 23, 2026, 7:52 PM EDT

Soleno Therapeutics Employees

Soleno Therapeutics had 182 employees as of December 31, 2025. The number of employees increased by 90 or 97.83% compared to the previous year.

Employees

182

Change

Growth

97.83%

Revenue / Employee

$1,046,181

Profits / Employee

$112,500

Market Cap

1.64B

Employees Chart

Date	Employees	Change (1Y)	Growth (1Y)
Dec 31, 2025	182	90	97.83%
Sep 30, 2025	152	60	65.22%
Jun 30, 2025	133	-	-
Mar 31, 2025	115	82	248.48%
Dec 31, 2024	92	59	178.79%
Dec 31, 2023	33	8	32.00%
Dec 31, 2022	25	5	25.00%
Dec 31, 2021	20	3	17.65%
Dec 31, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Sep 30, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Jun 30, 2020	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Sep 30, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Jun 30, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2017	Upgrade Pro	Upgrade Pro	Upgrade Pro
Dec 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Sep 30, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Jun 30, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro
Mar 31, 2016	Upgrade Pro	Upgrade Pro	Upgrade Pro

Company Name	Employees
Novavax	749
Recursion Pharmaceuticals	600
Agios Pharmaceuticals	540
Immunocore Holdings	524
Vericel	398
Intellia Therapeutics	377
Harmony Biosciences Holdings	293
Capricor Therapeutics	231